Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions

Journal of Pharmaceutical and Biomedical Analysis

Volumn 72, Issue , 2013, Pages 150-154

  Wallner, Jakob ^a   Lhota, Gabriele ^a   Jeschek, Dominik ^a   Mader, Alexander ^a   Vorauer Uhl, Karola ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Bio Layer interferometry; Biosensor; Erythropoietin; Liposomes; Protein membrane interactions

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; IMMOBILIZED PROTEIN; LIPOSOME; PHOSPHATIDYLCHOLINE; RECOMBINANT ERYTHROPOIETIN; STREPTAVIDIN;

ARTICLE; AUTOMATION; BINDING AFFINITY; BIO LAYER INTERFEROMETRY; BIOSENSOR; DRUG FORMULATION; INTERFEROMETRY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

BIOSENSING TECHNIQUES; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; ERYTHROPOIETIN; HORMONES; HUMANS; INTERFEROMETRY; KINETICS; LIPOSOMES; OPTICAL FIBERS; PROTEIN BINDING; RECOMBINANT PROTEINS; STREPTAVIDIN;

EID: 84869002011     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.10.008     Document Type: Article

References (31)

1. Peetla C., Stine A., Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol. Pharm. 2009, 6:1264-1276.
2. van De Waterbeemd H., Smith D.A., Beaumont K., Walker D.K. Property-based design: optimization of drug absorption and pharmacokinetics. J. Med. Chem. 2001, 44:1313-1333.
3. Papo N., Shai Y. Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides. Biochemistry 2003, 42:458-466.
4. Hidalgo I.J. Assessing the absorption of new pharmaceuticals. Curr. Top. Med. Chem. 2001, 1:385-401.
5. Alving C.R., Kinsky S.C., Haxby J.A., Kinsky C.B. Antibody binding and complement fixation by a liposomal model membrane. Biochemistry 1969, 8:1582-1587.
6. Apellaniz B., García-Sáez A.J., Huarte N., Kunert R., Vorauer-Uhl K., Katinger H., Schwille P., Nieva J.L. Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids. FEBS Lett. 2010, 584:1591-1596.
7. Zhong Z., Ji Q., Zhang J.A. Analysis of cationic liposomes by reversed-phase HPLC with evaporative light-scattering detection. J. Pharm. Biomed. Anal. 2010, 51:947-951.
8. Abdiche Y.N., Myszka D.G. Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal. Biochem. 2004, 328:233-243.
9. Barbour R., Bova M.P. Combining label-free technologies: discovery in strength. Bioanalysis 2012, 4:619-622.
10. Baird C.L., Courtenay E.S., Myszka D.G. Surface plasmon resonance characterization of drug/liposome interactions. Anal. Biochem. 2002, 310:93-99.
11. Frostell-Karlsson A., Widegren H., Green C.E., Hämäläinen M.D., Westerlund L., Karlsson R., Fenner K., van de Waterbeemd H. Biosensor analysis of the interaction between drug compounds and liposomes of different properties; a two-dimensional characterization tool for estimation of membrane absorption. J. Pharm. Sci. 2005, 94:25-37.
12. Maragos C.M. Detection of deoxynivalenol using biolayer interferometry. Mycol. Res. 2011, 27:157-165.
13. Abdiche Y., Malashock D., Pinkerton A., Pons J. Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. Anal. Biochem. 2008, 377:209-217.
14. Myszka D.G., Jonsen M.D., Graves B.J. Equilibrium analysis of high affinity interactions using BIACORE. Anal. Biochem. 1998, 265:326-330.
15. Strobach S., Kunert R., Stadlmann J., Messner P., Sevcsik E., Lhota G., Katinger H., Vorauer-Uhl K. Topological transformation of liposomes by a membrane-affecting domain of recombinant human erythropoietin. J. Liposome Res. 2010, 20:24-30.
16. Brines M., Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 2008, 264:405-432.
17. Um M., Gross A.W., Lodish H.F. A classical homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell. Signal. 2007, 19:634-645.
18. Do T., Ho F., Heidecker B., Witte K., Chang L., Lerner L. A rapid method for determining dynamic binding capacity of resins for the purification of proteins. Protein Expr. Purif. 2008, 60:147-150.
19. Bangham A.D., Standish M.M., Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965, 13:238-252.
20. Olson F., Hunt C.A., Szoka F.C., Vail W.J., Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 1979, 557:9-23.
21. Sélo I., Négroni L., Créminon C., Grassi J., Wal J.M. Preferential labeling of alpha-amino N-terminal groups in peptides by biotin: application to the detection of specific anti-peptide antibodies by enzyme immunoassays. J. Immunol. Methods 1996, 199:127-138.
22. Katsamba P.S., Navratilova I., Calderon-Cacia M., Fan L., Thornton K., Zhu M., Bos T.V., Forte C., Friend D., Laird-Offringa I., Tavares G., Whatley J., Shi E., Widom A., Lindquist K.C., Klakamp S., Drake A., Bohmann D., Roell M., Rose L., Dorocke J., Roth B., Luginbühl B., Myszka D.G. Kinetic analysis of a high-affinity antibody/antigen interaction performed by multiple Biacore user. Anal. Biochem. 2006, 352:208-221.
23. Abdiche Y.N., Malashock D.S., Pons J. Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors. Protein Sci. 2008, 17:1326-1335.
24. Holmberg A., Blomstergren A., Nord O., Lukacs M., Lundeberg J., Uhlen M. The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures. Electrophoresis 2005, 26:501-510.
25. Spector A.A., Yorek M.A. Membrane lipid composition and cellular function. J. Lipid Res. 1985, 26:1015-1035.
26. Koppenhagen F.J., Visser A.J., Herron J.N., Storm G., Crommelin D.J. Interaction of recombinant interleukin-2 with liposomal bilayers. J. Pharm. Sci. 1998, 87:707-714.
27. Van Slooten M.L., Boerman O., Romøren K., Kedar E., Crommelin D.J., Storm G. Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. Biochim. Biophys. Acta 2001, 1530:134-145.
28. Pasenkiewicz-Gierula M., Takaoka Y., Miyagawa H., Kitamura K., Kusumi A. Charge pairing of headgroups in phosphatidylcholine membranes: a molecular dynamics simulation study. Biophys. J. 1999, 76:1228-1240.
29. Dimitrova M., Matsumura H., Terezova N., Neytchev V. Binding of globular proteins to lipid membranes studied by isothermal titration calorimetry and fluorescence. Colloids Surf. B 2002, 24:53-61.
30. Brines M., Patel N.S., Villa P., Brines C., Mennini T., De Paola M., Erbayraktar Z., Erbayraktar S., Sepodes B., Thiemermann C., Ghezzi P., Yamin M., Hand C.C., Xie Q.W., Coleman T., Cerami A. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10925-10930.
31. Luo H.B., Zheng C., Cheng Y.K. Is phospholipid-saturated alkyl column a convenient replacement for immobilized-artificial-membrane?. J. Chromatogr. A 2007, 1176:100-106.